首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

1547660

全球豬隻疫苗市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Swine Vaccines Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球豬隻疫苗市場需求預計將從2023年的21.2億美元達到2032年近34.4億美元的市場規模，2024-2032年研究期間複合年成長率為5.52%。

疫苗似乎可以誘發保護性免疫力。它由來自病毒、細菌毒素、細菌或寄生蟲的抗原組成。將疫苗注射到豬體內以加速免疫反應，這將保護它們免受未來微生物的感染。豬疫苗可以是活疫苗，含有可在豬體內繁殖的活生物體，也可以是去活化疫苗，只包含不會在豬體內繁殖的去活化生物體。豬常用的疫苗有大腸桿菌腹瀉、仔豬梭菌性痢疾、丹毒、細小病毒感染、胸膜肺炎放線桿菌引起的壞死性胸膜肺炎、豬肺炎支原體引起的地方性肺炎、產毒多殺性巴氏桿菌引起的萎縮性鼻炎等。

市場動態

豬肉消費的增加、養豬業的升級以及為保護豬免受流行病和其他威脅而採取的預防措施的不斷加強，推動了全球對豬疫苗的需求。豬肉消費量的增加使得人們越來越需要使豬免受可能影響豬和威脅人類的所有可能的疾病的影響。感染、流行病和集約化生豬養殖的增加使得有效的疫苗接種在養豬業中勢在必行。豬隻呼吸與繁殖症候群、豬流行性腹瀉等疾病爆發，造成巨大損失。這些可以透過給懷孕母豬接種疫苗來控制。用於未滿足疾病疫苗創新的研發支出也有所成長。然而，維護和處理儲存條件的高額費用以及疫苗逆反應的可能性預計將阻礙全球豬隻疫苗的成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球豬隻疫苗市場的每個細分市場進行了包容性評估。豬疫苗產業的成長和趨勢為本研究提供了整體方法。

市場區隔

豬疫苗市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

減毒活疫苗
去活化疫苗
亞單位疫苗
DNA疫苗
重組疫苗

按類型

豬流感
古典豬瘟
豬細小病毒
豬圓環病毒2型
孝敏
胸膜肺炎放線桿菌
藍耳病
手足口病
偽狂犬病
PEDV
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲豬疫苗市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。豬疫苗市場的主要參與者包括默克公司、Ceva、碩騰、勃林格殷格翰有限公司、Elanco、Indian。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 8 章：豬疫苗公司的競爭格局

豬疫苗市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 9 章：公司簡介

頂級公司市佔率分析
市場集中度
Merck & Co. Inc

公司概況
公司收入
產品
最新動態

Ceva

公司概況
公司收入
產品
最新動態

Zoetis

公司概況
公司收入
產品
最新動態

BoehringerIngelheim GmbH

公司概況
公司收入
產品
最新動態

Elanco

公司概況
公司收入
產品
最新動態

Indian

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11214069

The global demand for Swine Vaccines Market is presumed to reach the market size of nearly USD 3.44 Billion by 2032 from USD 2.12 Billion in 2023 with a CAGR of 5.52% under the study period 2024-2032.

Vaccines appear to induce protective immunity. It consists of antigens from viruses, bacterial toxins, bacteria, or parasites. Vaccines are injected into swine to accelerate an immune response, which will protect them against future infection with the organism. Swine vaccines can be live, containing living organisms that will multiply in the pig, or inactivated, consisting only killed organisms that will not multiply in the swine. Vaccines commonly used on pig includes E. coli diarrhea, clostridial dysentery of piglets, erysipelas, parvovirus infection, necrotic pleuropneumonia caused by Actinobacillus pleuropneumoniae, enzootic pneumonia caused by Mycoplasma hyopneumoniae, and atrophic rhinitis caused by toxigenic Pasteurella multocida.

MARKET DYNAMICS

An increase in pork consumption, escalating swine industry, and growing precautions taken to protect swine from epidemics and other threats drive the demand for swine vaccines worldwide. Rising pork consumption has given rise to a growing need to keep the swine free from every possible disease that could affect swine and threaten the human population. The growth of infection, epidemics, and intensive pig operations has made effective vaccination imperative in the swine industry. Outbreaks of diseases such as porcine respiratory and reproductive syndrome (PRRS) and porcine epidemic diarrhea have caused massive losses. These are controlled by vaccinating pregnant sows. There has also been growth in R&D expenditure for the innovation of unmet disease vaccines. However, high expenses of maintaining and handling storage conditions and the chance of a reverse reaction from vaccines are projected to impede the growth of global swine vaccines.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Swine Vaccines. The growth and trends of Swine Vaccines industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Swine Vaccines market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines

By Type

Swine Influenza
Classical Swine Fever
Porcine Parvovirus
Porcine Circovirus Type 2
M.Hyo
Actinobacillus Pleuropneumonia
PRRS
Foot & Mouth Disease
Pseudorabies
PEDV
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Swine Vaccines market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Swine Vaccines market include Merck & Co. Inc, Ceva, Zoetis, BoehringerIngelheim GmbH, Elanco, Indian. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. SWINE VACCINES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Type
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL SWINE VACCINES MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data
5.3. Analysis By Product
5.4. Attenuated Live Vaccines Historic and Forecast Sales By Regions
5.5. Inactivated Vaccines Historic and Forecast Sales By Regions
5.6. Subunit Vaccines Historic and Forecast Sales By Regions
5.7. DNA Vaccines Historic and Forecast Sales By Regions
5.8. Recombinant Vaccines Historic and Forecast Sales By Regions

6. GLOBAL SWINE VACCINES MARKET ANALYSIS BY TYPE

6.1. Overview By Type
6.2. Historical and Forecast Data
6.3. Analysis By Type
6.4. Swine Influenza Historic and Forecast Sales By Regions
6.5. Classical Swine Fever Historic and Forecast Sales By Regions
6.6. Porcine Parvovirus Historic and Forecast Sales By Regions
6.7. Porcine Circovirus Type 2 Historic and Forecast Sales By Regions
6.8. M.Hyo Historic and Forecast Sales By Regions
6.9. Actinobacillus Pleuropneumonia Historic and Forecast Sales By Regions
6.10. PRRS Historic and Forecast Sales By Regions
6.11. Foot & Mouth Disease Historic and Forecast Sales By Regions
6.12. Pseudorabies Historic and Forecast Sales By Regions
6.13. PEDV Historic and Forecast Sales By Regions
6.14. Others Historic and Forecast Sales By Regions

7. GLOBAL SWINE VACCINES MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE SWINE VACCINES COMPANIES

8.1. Swine Vaccines Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF SWINE VACCINES INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Merck & Co. Inc
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Ceva
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Zoetis
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. BoehringerIngelheim GmbH
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Elanco
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Indian
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments